Nuo Therapeutics AURX
OTC AURX
$1.06 -0.07 (-6.19%)
As of: Nov 19, 2026 · 9:37 AM EST

Nuo Therapeutics (AURX) Return on Sales [ROS] (2009 - 2026)

Updated

Nuo Therapeutics' Return on Sales [ROS] was -20.06% in Q3 2026, up 32.27 percentage points from -52.33% a year earlier but down 10.65 percentage points from the prior quarter.

Analysis

Nuo Therapeutics (AURX) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nuo Therapeutics' Return on Sales [ROS] was -25.97% through Sep 30, 2026, up 72.31 percentage points year-over-year; for FY2025, it was -75.95%, up 104.09 percentage points from FY2024.

  • Return on Sales [ROS] has now increased for three consecutive years, with a three-year change of +2882.26 percentage points (FY2022 to FY2025).
  • In earlier years, Return on Sales [ROS] was -180.04% in FY2024 (+340.61 pp), -520.65% in FY2023 (+2437.56 pp) and -2958.21% in FY2022.
  • Quarterly Return on Sales [ROS] has moved between -2383.96% (Q3 2022) and -9.42% (Q2 2026) over five years.
  • Compared with a year earlier, Return on Sales [ROS] has increased for 13 straight quarters, with an average year-over-year change of +102.62 percentage points over the last eight quarters.
  • Over the past five years, the year-over-year gain in Return on Sales [ROS] ranged from 32.27 percentage points (Q3 2026) to 2043.99 percentage points (Q3 2023).
  • Per Business Quant data, AURX's Return on Sales [ROS] in the three quarters before Q3 2026 was -9.42% (Q2 2026), -34.29% (Q1 2026) and -52.82% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 247.92 Bn 224.44 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 178.73 Bn 152.60 Bn 7.39 Bn 10.44%
3 Danaher 155.17 Bn 134.82 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 139.71 Bn 120.00 Bn 2.08 Bn 19.44%
5 Medtronic 127.92 Bn 93.17 Bn 6.34 Bn 18.08%
6 Stryker 118.34 Bn 104.53 Bn 4.25 Bn 15.86%
7 Boston Scientific 61.10 Bn 56.53 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 58.81 Bn 42.02 Bn 1.35 Bn 17.44%
9 Agilent Technologies 47.86 Bn 40.75 Bn 1.04 Bn 23.64%
10 Nuo Therapeutics 44.28 Bn 44.28 Bn 1.19 Mn -20.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -20.06%
Jun 30, 2026 -9.42%
Mar 31, 2026 -34.29%
Dec 31, 2025 -52.82%
Sep 30, 2025 -52.33%
Jun 30, 2025 -93.12%
Mar 31, 2025 -153.83%
Dec 31, 2024 -159.35%
Sep 30, 2024 -155.65%
Jun 30, 2024 -148.58%
Mar 31, 2024 -302.35%
Dec 31, 2023 -330.99%
Sep 30, 2023 -339.97%
Jun 30, 2023 -737.44%
Mar 31, 2023 -1,399.66%
Dec 31, 2022 -1,301.60%
Sep 30, 2022 -2,383.96%
Sep 30, 2020 394.84%
Jun 30, 2020 -20.85%
Mar 31, 2020 -373.77%
API Access

Nuo Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AURX&period=max&api_key=YOUR_API_KEY